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Abstract 
The nucleophilic addition of organomagnesium and organolithium species to the cheap and robust 
natural dye indigo led to desymmetrisation of the heterocyclic nucleus via a Grignard addition-
dehydration procedure. Twenty-seven diversely-functionalised [1H,3ꞌH]-3-substituted-2,2ꞌ-diindol-
3ꞌ-ones were synthesised by this methodology, with several showing submicromolar inhibition and 
exquisite selectivity against P. falciparum parasites (3D7 and Dd2 strains) in vitro. This work 
demonstrates the utility of indigo dye as a highly-versatile scaffold for the synthesis of structurally-
diverse, bioactive heterocycles. 
 
 
Molecules containing the 2,2ꞌ-biindole moiety comprise a variety of natural products and 
pharmaceuticals, including the well-known indolocarbazole alkaloid staurosporine,1 trigonoliimine 
C, the iheyamines, and indimicins A-D,2,3 as well as midostaurin, which recently gained FDA 
approval4 for treatment of FLT3+ acute myeloid leukaemia under the name Rydapt. Multi-substituted 
2,2ꞌ-biindoles are uncommon, though a series of symmetrical 3,3ꞌ-diaryl-2,2ꞌ-biindoles were recently 
synthesised via oxidative dimerization, and determined to be low micromolar inhibitors of the 
Hedgehog signalling pathway.5 While non-symmetrical 1H-3ꞌH-2,2ꞌ-biindoles (indolenine-indoles) 
have received sporadic attention as either synthetic intermediates,6-11 or oxidation products,12-16 there 
are currently only three reported examples of the related [1H,3ꞌH]-2,2ꞌ-biindol-3ꞌ-one (3ꞌ-
oxoindolenine-indole) framework – the natural product bisindigotin,17 with a 1'H,3H-
[2,2':3',3'':2'',2'''-quaterindole] core (Scheme 1a), and a pair of intermediates integral to the Sperry 
group’s elegant synthesis18 of the iheyamine core and of iheyamine A itself. Neither the biological 
profile nor the synthetic utility of these types of molecules have been fully established owing to their 
scarcity, making access to substituted [1H,3ꞌH]-2,2ꞌ-biindol-3ꞌ-ones of considerable synthetic interest. 
 
Scheme 1: a: The sole previously-reported 1H,3ꞌH-2,2ꞌ-diindol-3ꞌ-ones – bisindigotin, and 
intermediates toward the synthesis of the 1H,3ꞌH-2,2ꞌ-biindol-3ꞌ-one iheyamine core and iheyamine 
A18; b: Previously-explored cascade reactions of indigo to generate highly-active antiplasmodials19; 
c: this work, a two-stage nucleophilic addition-dehydration for the synthesis of highly-selective 
antiplasmodials. 
Our continuing exploration of the nucleophilic cascade chemistry of indigo (1) has generated a variety 
of biologically-relevant heterocycles,20-22 with examples exhibiting high antiplasmodial potency 
(Scheme 1b; Compound 2 in vitro IC50 value 77 nM against P. falciparum 3D7 parasites) and low in 
vitro toxicity (selectivity index (SI) ratios >100).19 One limitation to our previous approach was the 
use of indigo exclusively as a nucleophile, initiating cascade reactions following treatment with a 
base. Recent studies have shown indigo to be a competent carbonyl-based electrophile, exemplified 
by reactions with arylamines in the presence of strong Lewis acids,23,24 and tandem acylation-
condensation reactions with substituted acyl chlorides,25-28 while older reports describe reactions of 
indigo’s carbonyl groups with amines, hydrazine, and hydroxylamine, among others.29-32 Given both 
the reported unreliability of some older methods,23,33 and that in near-to-all cases, these methods pre-
date all contemporary spectroscopic techniques, re-examination of indigo’s electrophilic potential is 
of considerable importance. Although the reaction of simple Grignard reagents was first noted in 
1909,34 it was confined to the nucleophilic addition only, with no subsequent elaboration, and just 
simple alkyl Grignard reagents used, with characterisation limited to chemical analysis. We report 
here a new methodology utilising the reaction of indigo with Grignard reagents (Scheme 1c) as a 
means of generating desymmetrised intermediates which may be elaborated toward a variety of 3-
substituted 2,2ꞌ-biindoles for subsequent medicinal chemistry studies. The reaction of indigo with 
various alkyl, aryl, and heterocyclic Grignard reagents is reported, with a view toward the discovery 
of new bioactive molecules. 
Reaction Optimisation 
Isopropylmagnesium chloride was initially selected as a model Grignard reagent for the optimisation 
of the proposed two-stage addition/elimination reaction (Scheme 2). Trialling various dehydrating 
agents (see SI for further details) revealed Boc2O to be the most reliable for dehydration of the alcohol 
intermediate. Initial attempts utilised a one-pot approach however strongly-coordinating Mg2+ and 
Li+ ions in the reaction mixture hindered dehydration, hence an intermediate aqueous workup prior 
to dehydration was necessary. After treatment of a suspension of indigo (0.5 mmol) in dry THF (20 
mL) with i-PrMgCl.LiCl (4.0 eq.), the resulting crude Grignard adduct 3 was cleanly dehydrated 
using Boc2O (3.0 eq.) at room temperature in the presence of both DMAP (2.2 eq.) and NEt3 (2.0 eq.), 
affording the desymmeterised diindole 4 in 80% yield over two steps. 
 
Scheme 2: Synthesis of compound 4 from the reaction of i-PrMgCl.LiCl (3) with indigo (1) and Boc-
mediated dehydration. 
The isopropylated diindole 4 was isolated as small, bright-orange crystals in 80% yield following 
SiO2 flash chromatography. Analysis of the HRESI mass spectrum revealed a peak at m/z 389.1860, 
assigned to the molecular ion [C24H25N2O3]
+, consistent with the addition of the N-Boc substituent, 
and the net substitution of one oxygen atom from indigo for the isopropyl group. Analysis of the 1H-
NMR spectrum revealed a 1H heptet resonance at δ 3.58 and a 6H doublet resonance at δ 1.46, 
assigned to the isopropyl moiety, and the presence of eight distinct aromatic resonances confirmed 
the desymmetrisation of the indigo core. The remaining 9H singlet at δ 1.49 was assigned as the 
protons of the tert-butyl carbamate group. Analysis of the 13C{1H}-DEPTQ spectrum indicated the 
presence of a single downfield resonance at δ 192.1, assigned as the ketone group of the 3H-indol-3-
one moiety, and the quaternary C2ꞌ was assigned to a deshielded resonance at δ 160.7. 
Substrate Scope 
To assess the generality of this method, a series of reactions were performed using commercially-
available organometallics, resulting in the isolation of the n-butyl (5, 80% from n-BuLi), benzyl (6, 
91% from the Grignard), and phenyl (7, 76% from the Grignard and 72% from phenyllithium) adducts 
in good yields. Treating the adduct of indigo and MeLi with Boc2O did not lead to deoxygenation, 
however Appel-type dehydration using PPh3.I2 with imidazole afforded the desired methyl-
substituted free indole 18 in 74% yield. Utilising the established protocols for directed ortho-lithiation 
of substituted aromatics,35 and in situ metalation of aryl halides with i-PrMgCl.LiCl,36 we sought to 
explore the reaction’s tolerance to a series of (hetero)aromatic Grignard reagents (Scheme 3), 
prepared from either their parent heterocycles, or the corresponding aryl iodide. A variety of both 
electron-rich and electron-poor aryl groups were tolerated, including those with methoxy- (8-11, 70-
94%), chloro- (12, 77%), and fluoro- (13, 74%) substituents at the meta, para, and ortho positions. 
In general, substrates containing electron-rich substituents ortho to the metalation site were typically 
high-yielding, due to the coordinating effect of the ortho-substituent allowing for faster initial 
insertion to the aryl C-I bond. The reaction also proved to be amenable to the addition of simple 
heterocycles, producing biindoles containing 2-thiophenyl (14, 93%), 3-pyridyl (15, 86%), 2-
benzofuranyl (16, 85%), and N-methylimidazol-2-yl (17, 93%) moieties, totalling fifteen isolated 
scaffolds. Additionally, the N-methylindol-5-yl moiety was incorporated in the desired 1'H,1''H,3H-
[2,2':3',5''-terindol]-3-one (19) in 78% crude yield, however this material decomposed upon attempted 
further purification. Analysis of the X-ray crystal structures of 7, 10, 12 and 14 (Figures S1-S4) shows 
that the planarity between the indolyl moieties of the indigo starting materials changing to dihedral 
angles of 60.3, 55.3 44.5 and 56.5 º, respectively, in-line with the size of the substituent. The dihedral 
angles of the indolyl-C3 aryl substituent were 46.8, 48.7, 57.0 and 37.7 º, respectively. 
 
Scheme 3: Reaction scope for the tandem addition-dehydration of indigo with Grignard and 
organolithium reagents. Percentages refer to yields from indigo over two steps. 
In all cases, the major side-products of this two-step sequence stemmed from unreacted indigo, 
isolated as mixtures of mono- or di-N-Boc-indigo in variable yields (5-20%), or products of undesired 
Wurtz-coupling of C4- or C7-metalated indigo (e.g. 4,4ꞌ-diisopropylindigo was isolated in a single 
run in 5% crude yield; numerous other minor side-products were also observed by TLC analysis), 
though these were readily removed by flash chromatography. Deprotection of the isolated N-Boc 
products 4-17 occurred under typical TFA-mediated conditions to give free indoles 20-30 in 69-96% 
yield (Scheme 4). The 3-methoxyphenyl, benzofuran-2-yl, and N-methylimidazol-2-yl adducts 9, 16, 
and 17 degraded rapidly upon Boc deprotection, and the desired indole products were not isolated. 
 
Scheme 4: Synthesis of free 1H,3'H-2,2'-biindolin-3'-ones 20-30 by Boc deprotection. Pictured are 
solutions of n-butyl adducts 5 (as N-Boc) and 21 (as N-H) in acetone at a concentration of ca. 1 mM, 
demonstrating their characteristic colour change. aCorrected yield (NMR). 
The pyridyl-substituted diindole 29 was isolated as an intense, deep-purple solid in 94% yield 
following SiO2
 flash chromatography. Analysis of the HRESI mass spectrum revealed a peak at m/z 
321.1142, assigned to the molecular ion [C21H14N3O]
+, consistent with protolysis of the N-Boc group. 
Analysis of the 1H NMR spectrum revealed a broad singlet at δ 10.40, which exchanged with D2O 
and was assigned to the indole NH group. A trio of resonances were observed at δ 8.95, δ 8.65, and 
δ 8.04, assigned to H2ꞌꞌ, H4ꞌꞌ, and H6ꞌꞌ respectively of the 3-pyridyl substituent. Analysis of the 
13C{1H}-DEPTQ spectrum revealed a lone carbonyl resonance at δ 195.9, assigned to C3ꞌ, while the 
indolenine C2ꞌ was shifted upfield to δ 153.9. The deep purple colour in solution was attributed to a 
wide absorptive band in the visible region between 480-600 nM – a common characteristic in the 
UV-Vis spectra for all twelve compounds 18, and 20-30. 
Mechanistic Discussion 
Despite the presence of excess nucleophile (4-5 eq.), indigo was only observed to undergo mono-
addition in all instances, consistent with the observed mono-selectivity in the original 1909 study, as 
determined by elemental analyses of the seven isolated adducts, which used large excesses (>10 eq.) 
of the Grignard reagent and without elaboration.34 Our study noted that visual observation of the 
mixture throughout the reaction revealed it to be self-indicating, where the mixture changed from a 
deep blue-black suspension to an intense crimson solution upon complete conversion, which 
dissipated to a dark gold upon hydrolysis, suggesting a metalated chelate intermediate of unknown 
constitution. It is likely the reaction proceeds via initial N-deprotonation of indigo, and complexation 
of the resulting di-anion to the Lewis acidic Mg2+ or Li+ ions. More favourable hard acid-base 
interaction via the non-symmetrical enolate 31 is likely to predominate, deactivating one carbonyl 
while leaving the other susceptible to nucleophilic attack, affording alcohol 32 upon workup. 
Treatment of 32 with Boc2O could then afford the intermediate carbonate 33, which could then 
undergo 1,4-conjugate elimination, with CO2 elimination
37-39 acting as an entropic driving force 
toward the formation of the non-symmetrical diindoles, isolated as their N-Boc adducts 4-17 (Scheme 
5). Steady evolution of gas was observed in all reactions, and the observation of tert-butanol in the 
crude NMR of the reaction mixture is not inconsistent with carbonate decomposition as the likely 
mechanistic pathway. 
 
Scheme 5: Plausible mechanism for the formation of nonsymmetric indoles 4-17 from indigo (1), via 
carbonate-assisted dehydration of alcohol adduct 32. 
Biological Activity 
An initial study of the biological profile of these molecules subjected the twelve final deprotected 
species to an in vitro antiplasmodial asexual assay to determine their efficacy as antimalarial agents 
against both chloroquine-resistant (Dd2) and -susceptible (3D7) strains of P. falciparum.40 Five 
showed highly-potent inhibition with submicromolar IC50 values against the 3D7 strain, with 
exceptionally-low human cell (HEK293) cytotoxicity (Table 1). The methyl adduct 18 proved the 
most potent with an IC50 value of 52 nM, and SI values in excess of >1500 (Entry 1), while the 
weakest inhibitor was the unsubstituted phenyl adduct 23 with an IC50 value of 6.91 μM. Previous 
studies into the mechanism of action of numerous 2-substituted 3H-indol-3-ones and 3H-indol-3-one-
N-oxides have shown that under hypoxic conditions, these molecules undergo GSH-mediated single-
electron reduction of the C=N moiety to an active radical species, leading to hyperphosphorylation 
of tyrosine residues and consequential membrane-cytoskeleton decoupling.41-44 Due to their structural 
homology, similar activity, and high selectivity, it is proposed that the new indole-substituted 3H-
indol-3-ones synthesised here act analogously. This is supported by the greater potency of the p-
fluorophenyl 28 (0.76 μM) and p-methoxyphenyl 22 (1.45 μM) adducts relative to their parent phenyl 
substituted derivative 23 (6.91 μM) due, at least in part, to increased radical stabilisation by these 
moieties.45 
Table 1: Summary of outcomes from antiplasmodial and cytotoxicity assays for compounds 18, and 
20-30 
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Compound 
3D7 IC50 
(nM) 
Dd2 IC50 
(nM) 
HEK293 IC50 
(nM) 
SI (HEK 
IC50/3D7 
IC50) 
1 18 51.8 ± 4.2 84.7 ± 11.1 22.9% at 80 μM
a >1500 
2 20 610 ± 40 811.1 ± 72.2 22394 ± 1432 36.7 
3 21 951 ± 289 841 ± 80 2.1% at 80 μM
a >84 
4 22 800 ± 167 747 ± 55.7 17.2% at 80 μM
a >100 
5 23 6911 ± 637 8236 ± 1321 4.2% at 80 μM
a >12 
6 24 1449 ± 264 1686 ± 311 1.1% at 80 μM
a >70 
7 25 5003 ± 1511 6543 ± 1018 3.2% at 80 μM
a >16 
8 26 3617 ± 173 4000 ± 544 4.7% at 80 μM
a >22 
9 27 5770 ± 1620 4948 ± 339 7.9% at 80 μM
a >14 
10 28 756 ± 128 733 ± 111 -0.6% at 80 μM
a >104 
11 29 5103 ± 1373 4207 ± 528 7.1% at 80 μM
a >15 
12 30 4145 ± 1115 3923 ± 255 3.6% at 80 μM
a >19 
13 Artesunate 6.0 ± 2.5 6.4 ± 2.2 35.7% at 10 μM
a >1666 
14 Chloroquine 29.3 ± 7.5 308.8 ± 82.7 56.2% at 40 μM
a -- 
15 Puromycin 100.4 ± 29.5 75.1 ± 22.5 819.6 ± 84.8 8.16 
16 Pyrimethamine 14.5 ± 2.8 17.3% at 40 μM
a 56.2% at 40 μMa -- 
17 Pyronaridine 14.4 ± 4.6 14.7 3572 ± 349 248 
a Percentage inhibition is given where an IC50 value could not be calculated due to the dose-response curve not 
reaching a full inhibition plateau at the maximum concentration. 
Conclusion 
We have established the Grignard addition to the cheap, robust, and plentiful indigo dye as the starting 
point for the generation of a variety of diverse, functionalised and desymmetrised 2,2ꞌ-diindoles in 
high yields over two steps. Where previously only three examples of [1H,3ꞌH]-2,2ꞌ-diindol-3ꞌ-ones 
were known, this new methodology allows general access to this molecular class bearing either N-H 
or N-Boc substituents, and featuring an array of useful functional moieties for further elaboration and 
medicinal chemistry studies, e.g. the –NH functionality in compounds 20-30 could be easily 
substituted to provide libraries of derivatives. Initial biological evaluation of these derived indolenine-
indoles revealed potent and highly-selective inhibition of P. falciparum parasites in vitro with IC50 
values as low as 52 nM and exceptionally low toxicity. Lead optimisation studies for medicinal 
application, and studies toward the synthesis of new, complex architectures using this new 
methodology are currently ongoing. 
Experimental Section 
General Information 
Reagents and solvents were purchased reagent grade and used without further purification unless 
otherwise stated. All reactions were performed in standard oven-dried glassware under CaCl2-
dried nitrogen gas unless otherwise stated. All yields reported are for compounds of greater than 
98% purity and are uncorrected, unless notated by a “†”, in which case, yields are NMR corrected 
yields. Indigo was purchased from AK Scientific and used without further purification. THF was 
dried by distillation from Na/benzophenone and stored over 3 Å molecular sieves prior to use. 
All solutions of Grignard or organolithium reagents were titrated prior to use, using either 2-
butanol or menthol in THF with 1,10-phenanthroline as indicator. Melting point temperatures 
are expressed in degrees Celsius (˚C) and are uncorrected. 1H and 13C{1H} NMR spectra (CDCl3) 
were recorded either at 500 MHz and 125 MHz, or 400 MHz and 101 MHz, respectively, with 
chemical shifts (δ) reported as parts per million relative to TMS (δ = 0.00 ppm), or CDCl3 (δ = 
7.26; 77.0 ppm). 19F NMR spectra (CDCl3) were recorded at 470 MHz or 377 MHz, with 
chemical shifts (δ) reported as parts per million relative to CFCl3 (δ = 0.00 ppm). Coupling 
constants (J) are reported in Hertz (Hz). Multiplicities are reported as singlets (s), doublets (d), 
triplets (t), doublet of doublets (dd), quartets (q), hextets (h), heptets (hept), or multiplets (m). 
Electrospray (ESI single quadrupole) mass spectra have their ion mass to charge values (m/z) 
stated with their relative abundances as a percentage in parentheses. Peaks assigned to the 
molecular ion are denoted as [M+H]+ or [M+Na]+. Infrared (IR) spectra were recorded neat. UV-
visible absorption spectra were recorded as solutions in acetone at room temperature. Thin layer 
chromatography (TLC) was performed using silica gel F254 aluminium sheets. Column 
chromatography was performed using silica gel 60 (0.063-0.200 mm). Eluents are reported in 
volume to volume (v:v) ratios. Solvent extracts and chromatographic fractions were concentrated 
by rotary evaporation in vacuo. Pet. spirit had a bp range of 40-60 ˚C.  
General Procedure A for Grignard Addition 
A solution of the Grignard reagent (2.50 mmol) in THF (5 mL) was added to a flame-dried round-
bottomed flask, equipped with a magnetic stir bar and pre-dried LiCl (106 mg, 2.50 mmol), and the 
mixture stirred vigorously at room temperature for 30 min. The resulting complex was added slowly 
dropwise to a cooled (0 ̊ C) suspension of indigo (131 mg, 0.500 mmol) in THF (15 mL) with vigorous 
stirring, and the resulting mixture allowed to warm to room temperature over 1 h, then stirred at room 
temperature overnight. To the mixture was added sat. aq. NaHCO3 (3 mL) and transferred to a 
separatory funnel containing further NaHCO3 solution (40 mL). The aqueous phase was extracted 
with EtOAc (4×40 mL), and the combined organic phases washed with further NaHCO3 solution (40 
mL) and brine (40 mL), dried (MgSO4), and the solvent removed. The residue was used directly for 
subsequent dehydration reactions. 
General Procedure B for Grignard Addition 
A solution of isopropylmagnesium chloride (titrated at 0.40–1.10 M, 2.00 mmol) in THF was added 
to a flame-dried round-bottomed flask, equipped with a magnetic stir bar and finely-powdered, pre-
dried LiCl (106 mg, 2.50 mmol), and the mixture stirred vigorously at room temperature for 30 min. 
The solution was cooled to 0 ˚C, and a solution of the desired aryl iodide (2.50 mmol) in THF (3 mL) 
added dropwise, and the mixture stirred for the indicated time. The resulting aryl Grignard reagent 
was added slowly dropwise to a cooled (-84 ˚C – EtOAc/N2) suspension of indigo (131 mg, 0.500 
mmol) in THF (15 mL) with vigorous stirring, and the resulting mixture allowed to warm to room 
temperature over 1 h and stirred at room temperature for a further hour. The reaction was quenched 
by addition of sat. aq. NaHCO3 (3 mL) and the mixture transferred to a separatory funnel containing 
further NaHCO3 solution (40 mL). The aqueous phase was extracted with EtOAc (4×40 mL), and the 
combined organic phases washed with further NaHCO3 solution (40 mL) and brine (40 mL), dried 
(MgSO4), and the solvent removed. The residue was used directly for subsequent dehydration 
reactions. 
General Procedure C for Grignard Addition 
A flame-dried round-bottomed flask, equipped with a magnetic stir bar was charged with a solution 
of the desired aryl iodide (2.50 mmol) in THF (1 mL), and cooled to 0 ˚C. Isopropylmagnesium 
chloride lithium chloride complex (titrated at 0.51 M, 2.00 mmol) in THF was added slowly dropwise, 
and the mixture stirred for the indicated time. The resulting aryl Grignard reagent was added slowly 
dropwise to a cooled (-84 ˚C – EtOAc/N2) suspension of indigo (131 mg, 0.500 mmol) in THF (15 
mL) with vigorous stirring, and the resulting mixture allowed to warm to room temperature over 1 h 
and stirred at room temperature for a further hour. The reaction was quenched by addition of sat. aq. 
NaHCO3 (3 mL) and transferred to a separatory funnel containing further NaHCO3 solution (40 mL). 
The aqueous phase was extracted with EtOAc (4×40 mL), and the combined organic phases washed 
with further NaHCO3 solution (40 mL) and brine (40 mL), and dried (MgSO4), and the solvent 
removed. The residue was used directly for subsequent dehydration reactions. 
General Procedure D for Organolithium Addition 
A flame-dried round-bottomed flask, equipped with a magnetic stir bar was charged with a solution 
of the desired heterocycle (2.50 mmol) in THF (1 mL), and cooled to -84 ˚C (EtOAc/N2). A solution 
of n-BuLi in hexane (titrated at 1.95 M, 2.00 mmol) was added slowly dropwise, and the mixture 
allowed to warm to room temperature over the indicated time. The resulting organolithium reagent 
was added slowly dropwise to a cooled (-84 ˚C) suspension of indigo (131 mg, 0.500 mmol) in THF 
(15 mL) with vigorous stirring, and the resulting deep red mixture allowed to warm to room 
temperature over 1 h, and stirred at room temperature for a further hour. The reaction was quenched 
by addition of sat. aq. NaHCO3 (3 mL), and the mixture transferred to a separatory funnel containing 
further NaHCO3 solution (40 mL). The aqueous phase was extracted with EtOAc (4×40 mL), and the 
combined organic phases washed with further NaHCO3 solution (40 mL) and brine (40 mL), dried 
(MgSO4), and the solvent removed. The residue was used directly for subsequent dehydration 
reactions. 
General Procedure E for Boc-mediated Dehydration: 
The crude tertiary alcohol residue (ca. 0.5 mmol) was suspended in CH2Cl2 (100 mL), then DMAP 
(131 mg, 1.1 mmol), NEt3 (0.2 mL) and di-tert-butyl dicarbonate (327 mg, 1.5 mmol) were added 
sequentially in air, and the mixture stirred vigorously at room temperature for 1 h. The resulting 
intense orange solution was diluted with 0.2 M HCl (50 mL), and the lower organic layer collected 
and washed with a further 0.2 M HCl (50 mL), sat. NaHCO3 (40 mL) and brine (40 mL), dried 
(Na2SO4) and the solvent removed. 
General Procedure F for Boc Deprotection: 
To a solution of the tert-butoxycarbonyl protected indole (ca. 0.1 mmol) in CH2Cl2 (0.1 M) was added 
neat trifluoroacetic acid (1 mL per 0.1 mmol of N-Boc indole). The resulting solution was stirred at 
room temperature for the indicated time, then diluted to ca. 20 mL with CH2Cl2, and transferred to a 
separatory funnel. The organic phase was repeatedly washed with sat. NaHCO3 solution until foaming 
ceased (typically 2-3×20 mL), the organic layer dried (Na2SO4), and the solvent removed. 
tert-butyl 3-isopropyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (4) 
Prepared via General Procedure A, using isopropylmagnesium chloride (0.598 M, 3.3 mL, 1.97 
mmol) and LiCl (106 mg, 2.50 mmol). Subsequent Boc-mediated dehydration (General Procedure 
E) of the crude product afforded a red residue, which was fractionated on silica (75 g, using 60% 
CH2Cl2:pet spirit as eluent) and recrystallised from hexane to afford the N-Boc indole 4 (153 mg, 
80%) as shiny, bright-orange crystals, mp 62-64 ˚C. Rf (10% EtOAc:pet spirit) 0.56. UV-Vis 
(acetone) λmax/nm (ε, M
-1cm-1) 333 (5448), 434 (1702), 509 (1275). 1H NMR (400 MHz, CDCl3) δ 
8.21 (d, J = 8.4 Hz, 1H, H7), 7.83 (d, J = 8.0 Hz, 1H, H4), 7.60 (d, J = 7.4 Hz, 1H, H4ꞌ), 7.56 (app t, 
J = 7.5 Hz, 1H, H6ꞌ), 7.49 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.40 (app t, J = 7.6 Hz, 1H, H6), 7.31 – 7.21 (m, 
2H, H5, H5ꞌ), 3.58 (hept, J = 7.1 Hz, 1H, H2ꞌꞌ), 1.49 (s, 9H, 3×Boc CH3), 1.46 (d, J = 7.1 Hz, 6H, 
H1ꞌꞌ, H3ꞌꞌ). 13C{1H} NMR (101 MHz, CDCl3) δ 192.1 (C3ꞌ), 160.8 (H7aꞌ), 160.7 (C2ꞌ), 150.1 (Boc 
C=O), 137.6 (C7a), 136.8 (C6ꞌ), 134.0 (C3), 128.52 (C3a or C3aꞌ), 128.50 (C3a or C3aꞌ), 128.4 (C5ꞌ), 
126.1 (C6), 125.0 (C4ꞌ), 124.2 (C2), 122.7 (C5), 122.5 (C7ꞌ), 121.8 (C4), 115.9 (C7), 84.9 (Boc Cq), 
28.1 (Boc CH3), 26.1 (C2ꞌꞌ), 22.8 (C1ꞌꞌ, C3ꞌꞌ). IR (neat) 2962 (w), 2929 (w), 2630 (w), 2339 (w), 1734 
(s), 1575 (m), 1452 (s), 1369 (s), 1344 (s), 1321 (s), 1234 (s), 1145 (s), 761 (s), 744 (s) cm-1. HRESI-
MS calcd. for C24H25N2O3
+ 389.1860, found 389.1860. 
tert-butyl 3-butyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (5) 
Prepared via General Procedure D, using n-BuLi (1.95 M, 1.4 mL, 2.73 mmol) and TMEDA (333 
mg, 2.86 mmol). Subsequent Boc-mediated dehydration (General Procedure E) of the crude product 
afforded a red-brown residue, which was fractionated on silica (75 g, using 10% EtOAc:hexane as 
eluent), and flash chromatography (30 g silica, 60% CH2Cl2:hexane) afforded the N-Boc indole 5 
(162 mg, 80%) as a deep orange amorphous solid, mp 42-43 ˚C. Rf (10% EtOAc:hexane) 0.49. UV-
Vis (acetone) λmax/nm (ε, M
-1cm-1) 331 (3679), 438 (2134), 500 (1810). 1H NMR (400 MHz, CDCl3) 
δ 8.17 (d, J = 8.4 Hz, 1H, H7), 7.65 (d, J = 7.7 Hz, 1H, H4), 7.62 – 7.53 (m, 2H, H4ꞌ, H6ꞌ), 7.48 (d, J 
= 7.6 Hz, 1H, H7ꞌ), 7.42 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H, H6), 7.34 – 7.26 (m, 2H, H5, H5ꞌ), 2.94 (d, J 
= 7.6 Hz, 2H, H1ꞌꞌ), 1.74 – 1.64 (m, 2H, H2ꞌꞌ), 1.51 (s, 9H, 3×Boc CH3), 1.36 (hex, J = 7.4 Hz, 2H, 
H3ꞌꞌ), 0.90 (t, J = 7.3 Hz, 3H, H4ꞌꞌ). 13C{1H} NMR (101 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.7 (C7aꞌ), 
160.2 (C2ꞌ), 150.0 (Boc C=O), 137.2 (C7a), 136.6 (C6), 129.8 (C3a), 129.3 (C3), 128.2 (C5ꞌ), 126.4 
(C6), 125.4 (C2), 124.8 (C4ꞌ), 122.9 (C5), 122.5 (C3aꞌ), 122.2 (C7ꞌ), 120.3 (C4), 115.6 (C7), 84.7 
(Boc Cq), 32.7 (C2ꞌꞌ), 28.0 (Boc CH3), 24.1 (C1ꞌꞌ), 22.6 (C3ꞌꞌ), 13.9 (C4ꞌꞌ). IR (neat) 2957 (w), 2930 
(w), 1734 (s), 1558 (m), 1319 (m) 1149 (s), 1105 (m), 761 (m), 745 (m) cm-1. HRESI-MS calcd. for 
C25H27N2O3
+ 403.2022, found 403.2036. 
tert-butyl 3-benzyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (6) 
Prepared via General Procedure A using benzylmagnesium chloride (1.89 M, 1.10 mL, 2.08 mmol), 
and LiCl (106 mg, 2.50 mmol). Subsequent Boc-mediated dehydration (General Procedure E) of the 
crude product afforded a deep orange residue, which was separated by flash chromatography (100 g 
silica, 10% EtOAc:hexane) to give the N-Boc indole 6 (204 mg, 91%) as a deep orange powder, mp 
85-86 ˚C. Rf (10% EtOAc:hexane) 0.27. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 331 (3957), 409 
(2129), 462 (1605), 499 (1561). 1H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 8.4 Hz, 1H, H7), 7.58 
(dd, J = 7.2, 0.6 Hz, 1H, H4ꞌ), 7.53 (td, J = 7.6, 1.2 Hz, 1H, H6ꞌ), 7.47 – 7.43 (m, 2H, H4, H7ꞌ), 7.38 
(ddd, J = 8.4, 7.2, 1.2 Hz, 1H, H6), 7.31 (d, J = 7.6 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.28 – 7.24 (m, 1H, H4ꞌꞌ), 7.22 
(dd, J = 10.9, 4.1 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 7.19 – 7.16 (m, 1H, H5), 7.13 (t, J = 7.4 Hz, 1H, H4ꞌꞌ), 4.32 (s, 
2H, Ar-CH2Ph), 1.53 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.5 
(C7aꞌ), 160.0 (C2ꞌ), 150.1 (Boc C=O), 139.7 (C1ꞌꞌ), 137.3 (C7a), 136.8 (C6ꞌ), 129.6 (C3a), 128.7 (C2ꞌꞌ, 
C6ꞌꞌ), 128.5 (C3ꞌꞌ, C5ꞌꞌ), 128.4 (C5ꞌ), 126.7 (C3), 126.6 (C6), 126.4 (C2), 126.3 (C4ꞌꞌ), 125.0 (C4ꞌ), 
123.2 (C5), 122.5 (C7aꞌ), 122.4 (C7ꞌ), 121.0 (C4), 115.6 (C7), 85.1 (Boc Cq), 30.6 (Ar-CH2Ph), 28.1 
(Boc CH3). IR (neat) 2979 (w), 1734 (s), 1558 (m), 1452 (m), 1319 (m) 1145 (s), 1105 (m), 762 (m), 
745 (m), 698 (m) cm-1. HRESI-MS calcd. for C28H25N2O3
+ 437.1865, found 437.1880. 
3-phenyl-1H,3'H-[2,2'-biindol]-3'-one (23) 
Prepared via General Procedure A using phenylmagnesium chloride (0.805 M, 2.50 mL, 2.01 mmol) 
and LiCl (106 mg, 2.50 mmol). Subsequent Boc-mediated dehydration (General Procedure E) of the 
crude product afforded a dark brown residue, which was fractionated on silica (40 g, using 60% 
CH2Cl2:pet spirit as eluent). Removal of the solvent from the first fraction afforded the free indole 23 
(22 mg, 11%†) as an intense black-purple powder, mp 190-192 ˚C. Rf (60% CH2Cl2:pet spirit) 0.58. 
UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 326 (2627), 538 (1491). 1H NMR (500 MHz, CDCl3) δ 10.25 
(s, 1H, NH), 7.70 (d, J = 7.6 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 7.67 (d, J = 8.1 Hz, 1H, H4), 7.54 – 7.45 (m, 5H, 
H4ꞌ, H7, H2ꞌꞌ, H6ꞌꞌ, H6ꞌ), 7.42 (t, J = 7.4 Hz, 1H, H4ꞌꞌ), 7.35 (t, J = 7.6 Hz, 1H, H6), 7.23 (d, J = 7.6 
Hz, 1H, H7ꞌ), 7.19 – 7.11 (m, 2H, H5, H5ꞌ). 13C{1H} NMR (126 MHz, CDCl3) δ 196.1 (C3ꞌ), 162.1 
(C7aꞌ), 154.3 (C2ꞌ), 138.2 (C7a), 137.5 (C6ꞌ), 133.9 (C1ꞌꞌ), 131.0 (C3ꞌꞌ, C5ꞌꞌ), 128.1 (C2ꞌꞌ, C6ꞌꞌ), 127.7 
(C4ꞌꞌ), 127.5 (C5ꞌ), 126.7 (C3a), 126.4 (C6), 125.2 (C4ꞌ), 124.5 (C3), 122.4 (C3aꞌ), 122.2 (C3aꞌ), 121.7 
(C4), 121.3 (C5), 114.2 (C2), 112.0 (C7). IR (neat) 3370 (br w), 2922 (s), 2850 (m), 1734 (m), 1558 
(s), 1168 (m), 747 (m) cm-1. HRESI-MS calcd. for C22H15N2O
+ 323.1184, found 323.1187. 
tert-butyl 3'-oxo-3-phenyl-1H,3'H-[2,2'-biindole]-1-carboxylate (7) 
Further elution afforded a red-orange fraction, which was subjected to flash chromatography (20 g 
silica, 10% EtOAc:pet spirit), and removal of the solvent gave the N-Boc indole 7 (174 mg, 76%†) as 
shiny, bright orange crystals, mp 132-133 ˚C (dec.). X-ray quality crystals were grown by slow 
evaporation from hexane. Rf (60% CH2Cl2:pet spirit) 0.56. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 
323 (7900), 329 (2917), 499 (1440). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.66 
– 7.60 (m, 3H, H2ꞌꞌ, H6ꞌꞌ, H4), 7.53 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 – 7.33 (m, 6H, H3ꞌꞌ, H4ꞌꞌ, H5ꞌꞌ, H6, 
H6ꞌ, H7ꞌ), 7.28 (app t, J = 7.2 Hz, 1H, H5), 7.23 (app t, J = 7.4 Hz, 1H, H5ꞌ), 1.52 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ 191.8 (C3ꞌ), 160.4 (C7aꞌ), 160.3 (C2ꞌ), 150.1 (Boc C=O), 136.8 
(C7a), 136.7 (C6ꞌ), 131.8 (C3), 130.9 (C3ꞌꞌ, C5ꞌꞌ), 129.6 (C3a), 128.5 (C5ꞌ), 128.3 (C2ꞌꞌ, C6ꞌꞌ), 128.1 
(C1ꞌꞌ), 128.0 (C7ꞌ), 126.7 (C6), 125.2 (C2), 125.0 (C4ꞌ), 123.5 (C5), 122.7 (C3aꞌ), 122.6 (C4ꞌꞌ), 121.2 
(C4), 115.7 (C7), 85.3 (Boc Cq), 28.1 (Boc CH3). IR (neat) 2978 (w), 2920 (w), 2360 (m), 1734 (s), 
1576 (m), 1319 (s) 1149 (s), 746 (s), 699 (s) cm-1. HRESI-MS calcd. for C27H23N2O3
+ 423.1703, 
found 423.1702. 
tert-butyl 3-(4-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (8) 
Prepared via General Procedure B. The substituted Grignard reagent (4-methoxyphenylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.80 
mL, 1.94 mmol), LiCl (106 mg, 2.50 mmol) and 4-iodoanisole (589 mg, 2.50 mmol), and the resulting 
mixture stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent Boc-
mediated dehydration (General Procedure E) of the crude product afforded a deep red-orange 
mixture, which was separated by flash chromatography (80 g silica, 10% EtOAc:pet spirit) to afford 
the title compound 8 (168 mg, 72%) as a bright orange powder, mp 79-80 ˚C (dec.). Rf (10% 
EtOAc:pet spirit) 0.25. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 347 (2250), 412 (1222), 469 (1104), 
504 (979). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.65 (d, J = 7.7 Hz, 1H, H4), 
7.60 (d, J = 8.7 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.55 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 
7.46 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H, H6), 7.40 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.30 (ddd, J = 8.1, 7.2, 1.0 Hz, 
1H, H5), 7.26 – 7.21 (m, 1H, H5ꞌ), 6.97 (d, J = 8.7 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.83 (s, 3H, -OCH3), 1.52 (s, 
9H, 3×Boc CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.6 (C7aꞌ), 160.3 (C2ꞌ), 159.5 
(C4ꞌꞌ), 150.1 (Boc C=O), 136.9 (C7a), 136.7 (C6ꞌ), 132.2 (C2ꞌꞌ, C6ꞌꞌ), 129.8 (C3a), 128.5 (C5ꞌ), 128.0 
(C3), 126.6 (C6), 125.0 (C4ꞌ), 124.9 (C2), 124.0 (C1ꞌꞌ), 123.5 (C5), 122.7 (C3aꞌ), 122.6 (C7ꞌ), 121.3 
(C4), 115.7 (C7), 113.7 (C3ꞌꞌ, C5ꞌꞌ), 85.2 (Boc Cq), 55.4 (-OCH3), 28.1 (Boc CH3). IR (neat) 2956 
(w), 2923 (m), 2853 (w), 1734 (s), 1506 (m), 1250 (s) 1151 (s), 763 (m) cm-1. HRESI-MS calcd. for 
C28H25N2O4
+ 453.1809, found 453.1807. 
tert-butyl 3-(3-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (9) 
Prepared via General Procedure B. The substituted Grignard reagent (3-methoxyphenylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.80 
mL, 1.94 mmol), LiCl (106 mg, 2.50 mmol), and 3-iodoanisole (599 mg, 2.56 mmol), and the 
resulting mixture stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent 
Boc-mediated dehydration (following General Procedure E) of the crude product afforded a deep 
red-orange residue, which was subjected to flash chromatography (95 g silica, 10% EtOAc:hexane), 
to afford the N-Boc indole 9 (167 mg, 70%†) as deep orange crystals, mp 64-65 ˚C. Rf (10% 
EtOAc:hexane) 0.25. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 327 (3430), 433 (1549), 467 (1357), 504 
(1143). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.69 (d, J = 7.9 Hz, 1H, H4), 
7.55 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 (td, J = 7.6, 1.2 Hz, 1H, H6ꞌ), 7.48 – 7.42 (m, 1H, H6), 7.37 (d, J 
= 7.5 Hz, 1H, H7ꞌ), 7.34 – 7.22 (m, 4H, H5, H5ꞌ, H2ꞌꞌ, H5ꞌꞌ), 7.20 – 7.16 (m, 1H, H6ꞌꞌ), 6.91 (ddd, J = 
8.2, 2.5, 0.8 Hz, 1H, H4ꞌꞌ), 3.83 (s, 3H, -OCH3), 1.52 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (101 MHz, 
CDCl3) δ 191.7 (C3ꞌ), 160.43 (C7aꞌ or C2ꞌ), 160.38 (C7aꞌ or C2ꞌ), 159.5 (C3ꞌꞌ), 150.1 (Boc C=O), 
136.8 (C7a), 136.7 (C6ꞌ), 133.0 (C1ꞌꞌ), 130.9 (C2), 129.5 (C3a), 129.2 (C5ꞌꞌ), 128.6 (C5ꞌ), 127.9 (C3), 
126.7 (C6), 125.0 (C4ꞌ), 123.6 (C5), 123.2 (C6ꞌꞌ), 122.7 (C3aꞌ), 122.6 (C7ꞌ), 121.2 (C4), 116.2 (C2ꞌꞌ), 
115.7 (C7), 114.4 (C4ꞌꞌ), 85.4 (Boc Cq), 55.4 (-OCH3), 28.1 (Boc CH3). IR (neat) 2976 (w), 2361 (m), 
2853 (w), 1734 (s), 1149 (s), 763 (m), 750 (m) cm-1. HRESI-MS calcd. for C28H25N2O4
+ 453.1809, 
found 453.1808. 
tert-butyl 3-(2-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (10) 
Prepared via General Procedure B. The substituted Grignard reagent (2-methoxyphenylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.80 
mL, 1.94 mmol), LiCl (106 mg, 2.50 mmol), and 2-iodoanisole (592 mg, 2.53 mmol), and the 
resulting mixture stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent 
Boc-mediated dehydration (General Procedure E) of the crude product afforded a deep red-orange 
residue, which was subjected to flash chromatography (80 g silica, 10% EtOAc:hexane), to afford the 
N-Boc indole 10 (217 mg, 94%) as deep orange crystals, mp 159-160 ˚C (dec.). X-ray quality crystals 
were grown by slow evaporation of a 9:1 hexane:chloroform solution. Rf (10% EtOAc:hexane) 0.24. 
UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 329 (2794), 419 (1496), 505 (948). 1H NMR (400 MHz, 
CDCl3) δ 8.25 (d, J = 8.4 Hz, 1H, H7), 7.61 – 7.53 (m, 3H, H6ꞌꞌ, H4, H4ꞌ), 7.47 (td, J = 7.8, 1.2 Hz, 
1H, H6ꞌ), 7.42 (ddd, J = 8.4, 7.3, 1.2 Hz, 1H, H6), 7.34 – 7.22 (m, 4H, H5, H5ꞌ, H7ꞌ, H4ꞌꞌ), 7.09 (td, J 
= 7.5, 0.9 Hz, 1H, H5ꞌꞌ), 6.83 (d, J = 8.0 Hz, 1H, H3ꞌꞌ), 3.37 (s, 3H, -OCH3), 1.51 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ 192.9 (C3ꞌ), 161.2 (C2ꞌ), 160.6 (C7aꞌ), 155.5 (C2ꞌꞌ), 149.9 (Boc 
C=O), 136.9 (C7a), 136.5 (C6ꞌ), 132.0 (C6ꞌꞌ), 129.6 (C3a), 129.2 (C4ꞌꞌ), 128.3 (C5ꞌ), 126.18 (C6), 
126.15 (C2), 124.4 (C4ꞌ), 123.4 (C5), 122.8 (C3aꞌ), 122.6 (C3), 122.3 (C7ꞌ), 121.1 (C1ꞌꞌ), 121.0 (C5ꞌꞌ), 
120.9 (C4), 115.8 (C7), 111.4 (C3ꞌꞌ), 85.1 (Boc Cq), 55.2 (-OCH3), 28.1 (Boc CH3). IR (neat) 2981 
(w), 2358 (w), 1718 (s), 1323 (s), 1149 (s), 748 (s) cm-1. HRESI-MS calcd. for C28H25N2O4
+ 
453.1809, found 453.1808. 
tert-butyl 3-(2,4-dimethoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (11) 
Prepared via General Procedure C. The substituted Grignard reagent (2,4-
dimethoxyphenylmagnesium chloride lithium chloride complex) was prepared using 
isopropylmagnesium chloride lithium chloride complex (0.45 M, 4.4 mL, 1.98 mmol), and 1-iodo-
2,4-dimethoxybenzene (664 mg, 2.51 mmol), and the mixture stirred at 0 ̊ C for 2 h prior to combining 
with indigo. Subsequent Boc-mediated dehydration (General Procedure E) of the crude product 
afforded a deep red-orange residue, which was subjected to flash chromatography (80 g silica, 20% 
EtOAc:hexane), to afford the N-Boc indole 11 (179 mg, 72%) as a deep orange solid, mp 89-90 ˚C 
(dec.). Rf (20% EtOAc:hexane) 0.35. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 330 (3138), 400 (1623), 
421 (1610), 507 (1127). 1H NMR (500 MHz, CDCl3) δ 8.24 (d, J = 8.5 Hz, 1H, H7), 7.59 (d, J = 7.1 
Hz, 1H, H4ꞌ), 7.54 (d, J = 8.0 Hz, 1H, H4), 7.50 – 7.45 (m, 2H, H6ꞌ, H6ꞌꞌ), 7.41 (app t, J = 7.2 Hz, 
1H, H6), 7.32 – 7.23 (m, 3H, H5, H5ꞌ, H7ꞌ), 6.63 (dd, J = 8.4, 2.4 Hz, 1H, H5ꞌꞌ), 6.40 (d, J = 2.4 Hz, 
1H, H3ꞌꞌ), 3.83 (s, 3H, C4ꞌꞌ-OCH3), 3.36 (s, 3H, C2ꞌꞌ-OCH3), 1.51 (s, 9H, 3×Boc CH3). 
13C{1H} NMR 
(126 MHz, CDCl3) δ 193.0 (C3ꞌ), 161.3 (C2ꞌ), 160.70 (C4ꞌꞌ or C7aꞌ), 160.65 (C4ꞌꞌ or C7aꞌ), 156.6 
(C2ꞌꞌ), 149.9 (Boc C=O), 136.9 (C7a), 136.5 (C6ꞌ), 132.5 (C6ꞌꞌ), 129.8 (C3a), 128.2 (C5ꞌ), 126.1 (C6), 
125.8 (C2), 124.4 (C4ꞌ), 123.3 (C5), 122.8 (C3aꞌ), 122.6 (C3), 122.3 (C7ꞌ), 120.9 (C4), 115.8 (C7), 
113.7 (C1ꞌꞌ), 104.8 (C5ꞌꞌ), 99.4 (C3ꞌꞌ), 85.0 (Boc Cq), 55.5 (C4ꞌꞌ-OCH3), 55.2 (C2ꞌꞌ-OCH3), 28.1 (Boc 
CH3). IR (neat) 2978 (w), 2933 (w), 2361 (w), 1734 (s), 1451 (m), 1323 (m), 1149 (s), 748 (s) cm
-1. 
HRESI-MS calcd. for C29H27N2O5
+ 483.1915, found 483.1914. 
tert-butyl 3-(2-chlorophenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (12) 
Prepared via General Procedure B. The substituted Grignard reagent (2-chlorophenylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.80 
mL, 1.94 mmol), LiCl (106 mg, 2.50 mmol), and 2-chloroiodobenzene (605 mg, 2.54 mmol), and the 
resulting mixture stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent 
Boc-mediated dehydration (General Procedure E) of the crude product afforded a deep red-orange 
residue, which was subjected to flash chromatography (80 g silica, 10% EtOAc:hexane), to afford the 
N-Boc indole 12 (182 mg, 77%†) as deep red-orange crystals, mp 108-109 ˚C (dec.). X-ray quality 
crystals were grown by slow evaporation of a 9:1 hexane:chloroform solution. Rf (10% 
EtOAc:hexane) 0.30. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 327 (3120), 401 (1619), 466 (1220), 500 
(952). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.5 Hz, 1H, H7), 7.57 (d, J = 7.2 Hz, 1H, H4ꞌ), 7.52 
(dd, J = 7.5, 1.7 Hz, 1H, H6ꞌꞌ), 7.49 – 7.45 (m, 2H, H6, H6ꞌ), 7.43 (dd, J = 5.4, 1.3 Hz, 1H, H3ꞌꞌ), 7.41 
– 7.39 (m, 1H, H4), 7.35 (dd, J = 7.4, 1.6 Hz, 1H, H5ꞌꞌ), 7.32 (dd, J = 7.6, 1.9 Hz, 1H, H4ꞌꞌ), 7.30 – 
7.27 (m, 3H, H5, H5ꞌ, H7ꞌ), 1.53 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ 191.8 
(C3ꞌ), 160.5 (C7aꞌ), 160.1 (C2ꞌ), 149.9 (Boc C=O), 136.8 (C7a), 136.6 (C6ꞌ), 133.6 (C2ꞌꞌ), 133.0 (C6ꞌꞌ), 
131.3 (C1ꞌꞌ), 130.0 (C3ꞌꞌ), 129.4 (C4ꞌꞌ), 129.2 (C3a), 128.5 (C5ꞌ), 128.4 (C2), 126.8 (C5ꞌꞌ), 126.7 (C6), 
126.6 (C3), 124.8 (C4ꞌ), 123.6 (C5), 122.54 (C3aꞌ), 122.52 (C7ꞌ), 121.0 (C4), 115.8 (C7), 85.5 (Boc 
Cq), 28.3 (Boc CH3). IR (neat) 2980 (w), 2931 (w), 2377 (w), 1734 (s), 1458 (m), 1320 (m), 1150 
(s), 748 (s) cm-1. HRESI-MS calcd. for C27H22
35ClN2O3
+ 457.1314, found 457.1313; calcd. for 
C27H22
37ClN2O3
+ 459.1284, found 459.1285.  
tert-butyl 3-(4-fluorophenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (13) 
Prepared via General Procedure B. The substituted Grignard reagent (4-fluorophenylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.70 
mL, 1.84 mmol), LiCl (106 mg, 2.50 mmol), and 4-fluoroiodobenzene (567 mg, 2.56 mmol), and the 
resulting mixture stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent 
Boc-mediated dehydration (General Procedure E) of the crude product afforded a deep red-orange 
residue, which was subjected to flash chromatography (80 g silica, 10% EtOAc:hexane), to afford the 
N-Boc indole 13 (167 mg, 74%†) as bright orange crystals, mp 137-138 ˚C (dec.). Rf (10% 
EtOAc:hexane) 0.53. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 329 (3911), 418 (2023), 470 (1725), 503 
(1448). 1H NMR (500 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.64 – 7.57 (m, 3H, H4, H2ꞌꞌ, 
H6ꞌꞌ), 7.56 (d, J = 7.1 Hz, 1H, H4), 7.52 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 7.47 (ddd, J = 8.4, 7.2, 1.2 Hz, 
1H, H6), 7.38 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.31 (app t, J = 7.1 Hz, 1H, H5), 7.29 – 7.22 (m, 1H, H5ꞌ), 
7.11 (app tt, J = 8.8, 2.9 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 1.53 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, 
CDCl3) δ 191.7 (C3ꞌ), 162.7 (d, 
1J C-F = 248.2 Hz, C4ꞌꞌ), 160.4 (C2ꞌ or C7aꞌ), 160.0 (C2ꞌ or C7aꞌ), 
150.2 (Boc C=O), 136.82 (C7a), 136.80 (C6ꞌ), 132.7 (d, 3J C-F = 8.1 Hz, C2ꞌꞌ, C6ꞌꞌ), 129.5 (C3a), 128.6 
(C5ꞌ), 127.7 (d, 4J C-F = 2.5 Hz, C1ꞌꞌ), 127.2 (C3), 126.8 (C6), 125.3 (C2), 125.1 (C4ꞌ), 123.6 (C5), 
122.7 (C3aꞌ), 122.6 (C7ꞌ), 121.0 (C4), 115.8 (C7), 115.3 (d, 2J C-F = 21.3 Hz, C3ꞌꞌ, C5ꞌꞌ), 85.5 (Boc 
Cq), 28.1 (Boc CH3).
 19F NMR (470 MHz, CDCl3, 
1H-decoupled) δ -114.0. IR (neat) 2980 (w), 2931 
(w), 2367 (w), 1734 (s), 1506 (m), 1319 (m), 1149 (s), 748 (s) cm-1. HRESI-MS calcd. for 
C27H22FN2O3
+ 441.1609, found 441.1608. 
tert-butyl 3'-oxo-3-(thiophen-2-yl)-1H,3'H-[2,2'-biindole]-1-carboxylate (14) 
Prepared via General Procedure B. The substituted Grignard reagent (thiophen-2-ylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride (1.08 M, 1.70 
mL, 1.84 mmol), LiCl (106 mg, 2.50 mmol), and 2-iodothiophene (537 mg, 2.56 mmol), and the 
mixture stirred at room temperature for 1 h prior to combining with indigo. Subsequent Boc-mediated 
dehydration (General Procedure E) of the crude product afforded a deep orange residue, which was 
subjected to flash chromatography (80 g silica, 10% EtOAc:hexane), to afford the N-Boc indole 14 
(210 mg, 93%†) as bright orange crystals, mp 78-79 ˚C (dec.). X-ray quality crystals were grown by 
evaporating a saturated 9:1 hexane:chloroform (1 mL) solution to ¼ its original volume, then the 
mother liquor removed from the precipitated solids and diluted with fresh hexane, and the resulting 
solution slowly evaporated. Rf (10% EtOAc:hexane) 0.42. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 328 
(5623), 436 (1945), 466 (1796), 506 (1540). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.4 Hz, 1H, 
H7), 7.94 (d, J = 7.9 Hz, 1H, H4), 7.60 (dd, J = 3.6, 1.1 Hz, 1H, H5ꞌꞌ), 7.59 – 7.52 (m, 2H, H4ꞌ, H6ꞌ), 
7.50 – 7.45 (m, 2H, H6, H7ꞌ), 7.40 (dd, J = 5.1, 1.1 Hz, 1H, H3ꞌꞌ), 7.35 (app t, J = 7.2 Hz, 1H, H5), 
7.28 (app t, J = 6.7 Hz, 1H, H5ꞌ), 7.14 (dd, J = 5.1, 3.6 Hz, 1H, H4ꞌꞌ), 1.52 (s, 9H, 3×Boc CH3).
 
13C{1H} NMR (101 MHz, CDCl3) δ 191.5 (C3ꞌ), 160.4 (C7aꞌ), 159.6 (C2ꞌ), 149.9 (Boc C=O), 136.9 
(C7a), 136.8 (C6ꞌ), 132.6 (C1ꞌꞌ), 129.6 (C5ꞌꞌ), 129.2 (C3a), 128.6 (C5ꞌ), 127.4 (C4ꞌꞌ), 126.9 (C6), 126.8 
(C3ꞌꞌ), 125.5 (C2), 125.1 (C4ꞌ), 123.7 (C5), 122.9 (C3aꞌ), 122.7 (C7ꞌ), 121.4 (C4), 121.1 (C3), 115.7 
(C7), 85.6 (Boc Cq), 28.1 (Boc CH3). IR (neat) 2979 (w), 2930 (w), 2373 (w), 1734 (s), 1558 (m), 
1319 (s), 1148 (s), 841 (m), 761 (m), 747 (s), 700 (m) cm-1. HRESI-MS calcd. for C25H21N2O3S
+ 
429.1267, found 429.1267. 
tert-butyl 3'-oxo-3-(pyridin-3-yl)-1H,3'H-[2,2'-biindole]-1-carboxylate (15) 
Prepared via General Procedure C. The substituted Grignard reagent (pyridin-3-ylmagnesium 
chloride lithium chloride complex) was prepared using isopropylmagnesium chloride lithium chloride 
complex (0.45 M, 4.4 mL, 1.98 mmol), and 3-iodopyridine (534 mg, 2.60 mmol), and the mixture 
stirred at room temperature for 1.5 h prior to combining with indigo. Subsequent Boc-mediated 
dehydration (General Procedure E) of the crude product afforded a deep orange residue, which was 
subjected to flash chromatography (80 g silica, 10% EtOAc:CH2Cl2), to afford the N-Boc indole 15 
(190 mg, 86%†) as a bright orange powder, mp 123-124 ˚C. Rf (10% EtOAc:CH2Cl2) 0.35. UV-Vis 
(acetone) λmax/nm (ε, M
-1cm-1) 338 (2624), 431 (2240), 463 (2057), 500 (1593). 1H NMR (500 MHz, 
CDCl3) δ 8.90 (s, 1H, H2ꞌꞌ), 8.60 (app s, 1H, H4ꞌꞌ), 8.26 (d, J = 8.5 Hz, 1H, H7), 8.02 (d, J = 7.8 Hz, 
1H, H6ꞌꞌ), 7.60 (d, J = 7.9 Hz, 1H, H4), 7.56 (d, J = 7.0 Hz, 1H, H4ꞌ), 7.52 (d, J = 7.8 Hz, 1H, H6ꞌ), 
7.48 (d, J = 8.3 Hz, 1H, H6), 7.40 – 7.35 (m, 2H, H7ꞌ, H5ꞌꞌ), 7.33 (app t, J = 7.5 Hz, 1H, H5), 7.28 – 
7.23 (m, 1H, H5ꞌ), 1.54 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 191.4 (C3ꞌ), 160.2 
(C7aꞌ), 159.6 (C2ꞌ), 151.4 (C2ꞌꞌ), 149.9 (Boc C=O), 149.1 (C4ꞌꞌ), 138.4 (C6ꞌꞌ), 136.9 (C7a), 136.8 
(C6ꞌ), 129.1 (C3a), 128.7 (C5ꞌ), 127.9 (C1ꞌꞌ), 127.0 (C6), 126.1 (C2), 125.1 (C4ꞌ), 124.4 (C3), 123.9 
(C5), 123.1 (C5ꞌꞌ), 122.7 (C7ꞌ), 122.6 (C3aꞌ), 120.6 (C4), 115.8 (C7), 85.7 (Boc Cq), 28.1 (Boc CH3). 
IR (neat) 2978 (w), 2933 (w), 1734 (s), 1559 (m), 1318 (s), 1149 (s), 909 (m), 763 (s), 731 (s), 715 
(s) cm-1. HRESI-MS calcd. for C26H22N3O3
+ 424.1656, found 424.1655. 
tert-butyl 3-(benzofuran-2-yl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (16) 
Prepared via General Procedure D. The substituted organolithium reagent (benzofuran-2-yllithium) 
was prepared using n-BuLi (1.95 M, 1.2 mL, 2.34 mmol), and benzofuran (299 mg, 2.53 mmol), and 
the mixture stirred for 1 h prior to combining with indigo. Subsequent Boc-mediated dehydration 
(General Procedure E) of the crude product afforded a deep orange residue, which was fractionated 
on silica (80 g, using 10% EtOAc:hexane as eluent), and the resulting deep red-orange residue 
subjected to flash chromatography (40 g silica, 60% CH2Cl2:pet spirit), to afford the N-Boc indole 16 
(200 mg, 85%) as a deep orange powder, mp 96-98 ˚C. Rf (10% EtOAc:hexane) 0.42. UV-Vis 
(acetone) λmax/nm (ε, M
-1cm-1) 332 (12256), 385 (3234), 436 (1841), 435 (2152), 510 (1797). 1H NMR 
(500 MHz, CDCl3) δ 8.29 – 8.23 (m, 2H, H4, H7), 7.64 – 7.59 (m, 2H, H4ꞌ, H4ꞌꞌ), 7.59 – 7.54 (m, 3H, 
H6ꞌ, H7ꞌ, H3ꞌꞌ), 7.50 (app t, J = 7.7 Hz, 1H, H6), 7.45 (d, J = 8.1 Hz, 1H, H7ꞌꞌ), 7.41 (app t, J = 7.6 
Hz, 1H, H5), 7.33 – 7.25 (m, 2H, H5ꞌ, H6ꞌꞌ), 7.24 – 7.19 (m, 1H, H5ꞌꞌ), 1.53 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 191.2 (C3ꞌ), 160.3 (C7aꞌ), 159.8 (C2ꞌ), 155.1 (C7aꞌꞌ), 149.8 (Boc 
C=O), 149.6 (C2ꞌꞌ), 137.0 (C7a), 136.8 (C6ꞌ), 128.8 (C5ꞌ), 128.7 (C3aꞌꞌ), 127.7 (C3a), 127.0 (C6), 
125.8 (C3), 125.2 (C4ꞌ), 124.8 (C6ꞌꞌ), 124.0 (C5), 123.0 (C5ꞌꞌ), 122.8 (C3aꞌ), 122.70 (C4), 122.66 
(C7ꞌ), 121.4 (C4ꞌꞌ), 117.2 (C2), 115.6 (C7), 111.2 (C7ꞌꞌ), 108.1 (C3ꞌꞌ), 85.8 (Boc Cq), 28.1 (Boc CH3). 
IR (neat) 2977 (w), 2932 (w), 1734 (s), 1717 (m), 1559 (s), 1507 (m), 1317 (m), 1148 (s), 761 (m), 
747 (s) cm-1. HRESI-MS calcd. for C29H22N2O4Na
+ 485.1477, found 485.1479. 
tert-butyl 3-(1-methyl-imidazol-2-yl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (17) 
Prepared via General Procedure D. The substituted organolithium reagent ((1-methyl-1H-imidazol-
2-yl)lithium) was prepared using n-BuLi (1.95 M, 1.15 mL, 2.24 mmol), and N-methylimidazole (217 
mg, 2.64 mmol), and the mixture stirred for 1.5 h prior to combining with indigo. Subsequent Boc-
mediated dehydration (General Procedure E) of the crude product afforded a deep orange residue, 
which was subjected to flash chromatography (25 g silica, 20% EtOAc:CH2Cl2), to afford the N-Boc 
indole 17 (204 mg, 93%) as a deep orange-brown solid, mp 101-102 ̊ C. Rf (10% MeCN:CHCl3) 0.46. 
UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 334 (2215), 436 (1841), 465 (1653), 501 (1296). 1H NMR 
(500 MHz, CDCl3) δ 8.21 (d, J = 8.5 Hz, 1H, H7), 7.56 – 7.51 (m, 2H, H4, H4ꞌ), 7.51 – 7.43 (m, 2H, 
H6, H6ꞌ), 7.37 – 7.28 (m, 2H, H5, H7ꞌ), 7.25 (app t, J = 7.5 Hz, 1H, H5ꞌ), 7.16 (app s, 1H, H4ꞌꞌ), 7.04 
(app s, 1H, H5ꞌꞌ), 3.68 (s, 3H, -NCH3), 1.55 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, CDCl3) 
δ 190.9 (C3ꞌ), 160.2 (C7aꞌ), 159.7 (C2ꞌ), 149.8 (Boc C=O), 140.1 (C2ꞌꞌ), 136.9 (C7a), 136.7 (C6ꞌ), 
129.5 (C3a), 129.4 (C4ꞌꞌ), 128.7 (C2), 128.6 (C5ꞌ), 127.0 (C6), 125.0 (C4ꞌ), 123.9 (C5), 122.6 (C7ꞌ), 
122.4 (C3aꞌ), 121.9 (C5ꞌꞌ), 121.5 (C4), 117.0 (C3), 115.5 (C7), 85.7 (Boc Cq), 34.3 (-NCH3), 28.1 
(Boc CH3). IR (neat) 2980 (w), 2933 (w), 1734 (s), 1559 (m), 1456 (m), 1369 (m), 1315 (s), 1149 (s), 
909 (m), 763 (s), 748 (s), 731 (s) cm-1. HRESI-MS calcd. for C25H23N4O3
+ 427.1765, found 427.1764. 
3-methyl-1H,3'H-[2,2'-biindol]-3'-one (18) 
To a cooled (-84 ˚C) suspension of indigo (131 mg, 0.500 mmol) and TMEDA (320 mg, 2.75 mmol) 
in THF (20 mL) was added dropwise MeLi (2.74 M in DME, 0.90 mL, 2.47 mmol), and the mixture 
allowed to warm to RT over 1 h. The resulting intense-red solution was stirred at RT for a further 
hour, then sat. NaHCO3 solution (3 mL) added, and the mixture transferred to a separatory funnel 
containing additional NaHCO3 solution (40 mL). The aqueous phase was extracted with EtOAc (4×40 
mL), and the combined organic phases washed with NaHCO3 solution (40 mL) and brine (40 mL), 
dried (MgSO4), and the solvent removed. The resulting golden residue was dissolved in CH2Cl2 (100 
mL), then PPh3 (159 mg, 0.606 mmol), imidazole (99 mg, 1.46 mmol), and I2 (162 mg, 0.638 mmol) 
added sequentially. The deep brown mixture was stirred overnight, then diluted with water (50 mL) 
and transferred to a separatory funnel. The aqueous phase was extracted with CH2Cl2 (3×30 mL), and 
the combined organic phases washed with NaHCO3 solution (40 mL) and brine (40 mL), dried 
(MgSO4), and the solvent removed. The residue was subjected to flash chromatography (60 g silica, 
60% CH2Cl2:pet spirit) and removal of the solvent from the intense deep-purple fraction afforded the 
desired indole 18 (97 mg, 74%) as feathery, dark purple crystals, mp 252-253 ˚C (dec.). Rf (60% 
CH2Cl2:pet spirit) 0.71. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 326 (8389), 538 (4881). 1H NMR 
(500 MHz, CDCl3) δ 9.98 (s, 1H, NH), 7.68 (dd, J = 8.1, 1.0 Hz, 1H, H4), 7.58 – 7.50 (m, 2H, C4ꞌ, 
C7ꞌ), 7.43 – 7.36 (m, 2H, H7, H6ꞌ), 7.32 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H, H6), 7.22 – 7.16 (m, 1H, H5ꞌ), 
7.16 – 7.11 (m, 1H, H5), 2.84 (s, 3H, Ar-CH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 196.9 (C3ꞌ), 
163.0 (C7aꞌ), 154.8 (C2ꞌ), 138.4 (C7a), 137.7 (C6ꞌ), 128.8 (C3a), 127.4 (C5ꞌ), 126.3 (C6), 125.23 (C2), 
125.19 (C4ꞌ), 124.3 (C3aꞌ), 122.04 (C3), 121.95 (C7ꞌ), 120.7 (C4), 120.4 (C5), 112.0 (C7), 11.6 (Ar-
CH3). IR (neat) 3376 (m), 1708 (s), 1540 (s), 1452 (m), 1327 (s), 1241 (m), 1167 (s), 877 (m), 762 
(s), 741 (s), 672 (s) cm-1. HRESI-MS calcd. for C17H13N2O
+ 261.1022, found 261.1022. 
tert-butyl 1''-methyl-3-oxo-1'H,1''H,3H-[2,2':3',5''-terindole]-1'-carboxylate (19) 
A solution of isopropylmagnesium chloride lithium chloride complex (titrated at 0.512 M, 3.90 mL, 
2.00 mmol) in THF was added slowly to a flame-dried round-bottomed flask, containing a magnetic 
stir bar and 5-iodo-N-methylindole (651 mg, 2.53 mmol), and the mixture stirred vigorously at 0 ˚C 
for 2 h. The resulting aryl Grignard reagent was added slowly dropwise to a cooled (-84 ˚C – 
EtOAc/N2) suspension of indigo (131 mg, 0.500 mmol) in THF (15 mL) with vigorous stirring, and 
the resulting mixture allowed to warm to room temperature over 1 h and stirred at room temperature 
for a further hour. The reaction was quenched by addition of sat. aq. NaHCO3 (3 mL) and the mixture 
transferred to a separatory funnel containing further NaHCO3 solution (40 mL). The aqueous phase 
was extracted with EtOAc (4×40 mL), and the combined organic phases washed with further NaHCO3 
solution (40 mL) and brine (40 mL), dried (MgSO4), the solvent removed, and the resulting residue 
used directly. The crude adduct was suspended in CH2Cl2 (100 mL), then DMAP (131 mg, 1.1 mmol), 
NEt3 (0.2 mL) and di-tert-butyl dicarbonate (327 mg, 1.5 mmol) were added sequentially in air, and 
the mixture stirred vigorously at room temperature for 1 h. The resulting intense orange solution was 
diluted with 0.2 M HCl (50 mL), and the lower organic layer collected and washed with a further 0.2 
M HCl (50 mL), sat. NaHCO3 (40 mL) and brine (40 mL), dried (Na2SO4) and the solvent removed. 
The bright orange residue was subjected to flash chromatography (100 g silica, 10% EtOAc:hexane), 
to afford the crude N-Boc terindole 19 (186 mg, 78% crude yield, 61% corrected NMR yield) as a 
bright orange amorphous solid, isolated alongside an unknown impurity which proved non-separable 
by all trialled separation techniques, including recrystallisation, PTLC separation (40% 
hexane:CH2Cl2; 10% EtOAc:hexane) and repeated flash chromatographic separation (2-20% 
EtOAc:hexane). Rf (10% EtOAc:pet spirit) 0.28. 
1H NMR (500 MHz, CDCl3) δ 8.26 (d, J = 8.4 Hz, 
1H, H7), 7.93 (d, J = 1.0 Hz, 1H, H4ꞌꞌ), 7.68 (d, J = 7.8 Hz, 1H, H4), 7.52 (d, J = 7.1 Hz, 1H, H4ꞌ), 
7.49 – 7.42 (m, 3H, H6, H6ꞌ, H6ꞌꞌ), 7.37 – 7.32 (m, 2H, H7ꞌ, H7ꞌꞌ), 7.28 (app t, J = 7.1 Hz, 1H, H5), 
7.21 (dd, J = 7.3, 0.8 Hz, 1H, H5ꞌ), 7.06 (d, J = 3.1 Hz, 1H, H2ꞌꞌ), 6.52 (d, J = 2.3 Hz, 1H, H3ꞌꞌ), 3.80 
(s, 3H, N1ꞌꞌCH3), 1.52 (s, 9H, 3×Boc CH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 192.0 (C3ꞌ), 160.5 
(C7aꞌ), 160.4 (C2ꞌ), 150.1 (Boc C=O), 136.9 (C7a or C7aꞌꞌ), 136.6 (C6ꞌ), 136.5 (C7a or C7aꞌꞌ), 130.2 
(C3a), 129.7 (C2), 129.4 (C2ꞌꞌ), 129.0 (C3), 128.4 (C5ꞌ), 128.1 (C3aꞌꞌ), 126.4 (C6), 124.9 (C4ꞌ or C6ꞌꞌ), 
124.8 (C4ꞌ or C6ꞌꞌ), 123.5 (C4ꞌꞌ), 123.2 (C5), 122.6 (C5ꞌꞌ), 122.5 (C3aꞌ), 122.4 (C7ꞌ), 121.5 (C4), 115.6 
(C7), 109.0 (C7ꞌꞌ), 101.6 (C3ꞌꞌ), 84.9 (Boc Cq), 32.9 (N1ꞌꞌCH3), 27.3 (Boc CH3). HRESI-MS calcd. 
for C30H26N3O3
+ 476.1969, found 476.1968. 
3-isopropyl-1H,3'H-[2,2'-biindol]-3'-one (20) 
Prepared via General Procedure F, using 48.4 mg (0.124 mmol) of 4, and a 1 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and triturated with hot hexane to afford the desired indole 20 (33.0 mg, 89%†) as an 
intense, black-purple powder, mp 168-170 ̊ C (dec.). Rf (10% EtOAc:hexane) 0.56. UV-Vis (acetone) 
λmax/nm (ε, M
-1cm-1) 302 (7209), 552 (1594). 1H NMR (400 MHz, CDCl3) δ 10.11 (s, 1H, NH), 7.92 
(d, J = 8.3 Hz, 1H, H4), 7.57 – 7.49 (m, 2H, H4ꞌ, H6ꞌ), 7.42 (d, J = 8.3 Hz, 1H, H7), 7.37 (d, J = 7.5 
Hz, 1H, H7ꞌ), 7.32 – 7.27 (m, 1H, H6), 7.18 (app t, J = 7.1 Hz, 1H, H5ꞌ), 7.11 – 7.05 (m, 1H, H5), 
4.55 (hept, J = 7.0 Hz, 1H, H2ꞌꞌ), 1.54 (d, J = 7.1 Hz, 6H, H1ꞌꞌ, H3ꞌꞌ). 13C{1H} NMR (101 MHz, 
CDCl3) δ 197.1 (C3ꞌ), 162.7 (C7aꞌ), 154.6 (C2ꞌ), 138.8 (C7a), 137.5 (C6ꞌ), 135.0 (C3), 127.3 (C5ꞌ), 
126.6 (C3a), 125.7 (C6), 125.1 (C4ꞌ), 123.8 (C2), 122.6 (C4), 121.9 (C7ꞌ), 121.7 (C3aꞌ), 119.8 (C5), 
112.3 (C7), 26.5 (C2ꞌꞌ), 22.6 (C1ꞌꞌ, C3ꞌꞌ). IR (neat) 3378 (m), 1709 (s), 1540 (s), 1451 (m), 1329 (s), 
1240 (m), 1168 (s), 875 (m), 761 (s), 741 (s), 672 (s) cm-1. HRESI-MS calcd. for C19H17N2O
+ 
289.1341, found 289.1353. 
3-butyl-1H,3'H-[2,2'-biindol]-3'-one (21) 
Prepared via General Procedure F, using 43.6 mg (0.108 mmol) of 5, and a 1.5 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and removal of the solvent afforded the desired indole 21 (29.8 mg, 91%) as an 
intense, black-purple powder, mp 131-132 ˚C. Rf (10% EtOAc:hexane) 0.45. UV-Vis (acetone) 
λmax/nm (ε, M
-1cm-1) 327 (2462), 542 (1654). 1H NMR (400 MHz, CDCl3) δ 10.00 (s, 1H, NH), 7.71 
(dd, J = 8.2, 1.0 Hz, 1H, H4), 7.58 – 7.49 (m, 2H, H4ꞌ, H6ꞌ), 7.41 (d, J = 8.3 Hz, 1H, H7), 7.36 (d, J 
= 7.6 Hz, 1H, H7ꞌ), 7.33 – 7.28 (m, 1H, H6), 7.22 – 7.13 (m, 1H, H5ꞌ), 7.12 (ddd, J = 8.0, 6.9, 1.0 Hz, 
1H, H5), 3.37 (t, J = 7.7 Hz, 2H, H1ꞌꞌ), 1.80 – 1.68 (m, 2H, H2ꞌꞌ), 1.47 (h, J = 7.4 Hz, 2H, H3ꞌꞌ), 0.97 
(t, J = 7.4 Hz, 3H, H4ꞌꞌ). 13C{1H} NMR (101 MHz, CDCl3) δ 197.0 (C3ꞌ), 163.0 (C7aꞌ), 154.6 (C2ꞌ), 
138.4 (C7a), 137.6 (C6ꞌ), 129.7 (C3), 128.4 (C3a), 127.3 (C5ꞌ), 126.2 (C6), 125.1 (C4ꞌ), 125.0 (C2), 
122.1 (C3aꞌ), 122.0 (C4), 120.9 (C7ꞌ), 120.3 (C5), 112.0 (C7), 32.7 (C2ꞌꞌ), 25.4 (C1ꞌꞌ), 23.0 (C3ꞌꞌ), 14.2 
(C4ꞌꞌ). IR (neat) 3382 (m), 2955 (w), 2924 (w), 1715 (s), 1551 (s), 1449 (m), 1340 (w), 1237 (w), 
1170 (m), 877 (w), 761 (m), 740 (m) cm-1. HRESI-MS calcd. for C20H19N2O
+ 303.1497, found 
303.1508. 
3-benzyl-1H,3'H-[2,2'-biindol]-3'-one (22) 
Prepared via General Procedure F, using 65.3 mg (0.150 mmol) of 6, and a 1.5 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and triturated with hexane to give the desired indole 22 (35.7 mg, 69%†) as an 
intense, black-purple powder, mp 139-140 ̊ C (dec.). Rf (10% EtOAc:hexane) 0.36. UV-Vis (acetone) 
λmax/nm (ε, M
-1cm-1) 327 (5752), 355 (4608), 537 (1655). 1H NMR (500 MHz, CDCl3) δ 10.09 (s, 
1H), 7.59 (d, J = 8.2 Hz, 1H, H4), 7.54 (d, J = 7.0 Hz, 1H, H4ꞌ), 7.51 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 
7.41 (d, J = 8.4 Hz, 1H, H7), 7.38 (d, J = 7.0 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.35 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.29 
(ddd, J = 8.2, 6.9, 1.1 Hz, 1H, H6), 7.23 (dd, J = 8.3, 6.9 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 7.18 (td, J = 7.5, 0.9 Hz, 
1H, H5ꞌ), 7.16 – 7.12 (m, 1H, H4ꞌꞌ), 7.08 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H, H5), 4.81 (s, 2H, Ar-CH2Ph). 
13C{1H} NMR (126 MHz, CDCl3) δ 196.7 (C3ꞌ), 162.6 (C7aꞌ), 154.4 (C2ꞌ), 141.1 (C1ꞌꞌ), 138.3 (C7a), 
137.5 (C6ꞌ), 128.8 (C2ꞌꞌ), 128.24 (C3ꞌꞌ), 128.17 (C3a), 127.4 (C5ꞌ), 126.3 (C3), 126.1 (C6), 125.8 
(C4ꞌꞌ), 125.2 (C2), 125.1 (C4ꞌ), 122.0 (C4), 121.9 (C3aꞌ), 121.1 (C7ꞌ), 120.5 (C5), 112.0 (C7), 31.3 
(Ar-CH2Ph). IR (neat) 3421 (w), 2919 (w), 1734 (s), 1717 (s) 1558 (s), 1507 (s), 1457 (m), 1339 (w), 
1237 (w), 1167 (m), 745 (s) cm-1. HRESI-MS calcd. for C23H17N2O
+ 337.1341, found 337.1326. 
3-phenyl-1H,3'H-[2,2'-biindol]-3'-one (23) 
Prepared via General Procedure F, using 51.1 mg (0.121 mmol) of 7, and a 2 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% EtOAc:pet 
spirit), and removal of the solvent gave the desired indole 23 (31.6 mg, 81%) as an intense, black-
purple powder. Spectral and physical characteristics were identical to those reported above. 
3-(4-methoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (24) 
Prepared via General Procedure F, using 31.8 mg (0.070 mmol) of 8, and a 1.5 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and removal of the solvent gave the desired indole 24 (23.6 mg, 95%) as intense, 
black-purple crystals, mp 227-228 ˚C. Rf (10% EtOAc:hexane) 0.33. UV-Vis (acetone) λmax/nm (ε, 
M-1cm-1) 327 (3173), 337 (3174), 390 (1478), 541 (1016). 1H NMR (500 MHz, CDCl3) δ 10.26 (s, 
1H, NH), 7.70 – 7.65 (m, 3H, H4, H2ꞌꞌ, H6ꞌꞌ), 7.52 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.49 – 7.45 (m, 2H, H7, 
H6ꞌ), 7.35 (ddd, J = 8.2, 6.9, 1.0 Hz, 1H, H6), 7.24 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.19 – 7.12 (m, 2H, H5, 
H5ꞌ), 7.04 (d, J = 8.8 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.91 (s, 3H, -OCH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 
196.6 (C3ꞌ), 162.4 (C7aꞌ), 159.1 (C2ꞌ), 154.1 (C4ꞌꞌ), 138.3 (C7a), 137.5 (C6ꞌ), 132.3 (C2ꞌꞌ, C6ꞌꞌ), 128.2 
(C3), 127.6 (C5ꞌ), 126.8 (C3a), 126.4 (C6), 126.1 (C2), 125.2 (C4ꞌ), 124.3 (C1ꞌꞌ), 122.4 (C4), 122.2 
(C3aꞌ), 121.8 (C7ꞌ), 121.2 (C5), 113.6 (C3ꞌꞌ, C5ꞌꞌ), 112.0 (C7), 55.4 (-OCH3). IR (neat) 3374 (w), 3349 
(w), 1710 (s), 1539 (s), 1444 (s), 1320 (m), 1251 (m), 1166 (s), 877 (m), 832 (s), 758 (m), 744 (s), 
691 (s) cm-1. HRESI-MS calcd. for C23H17N2O2
+ 353.1290, found 353.1280. 
3-(2-methoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (25) 
Prepared via General Procedure F, using 70.9 mg (0.157 mmol) of 10, and a 1.5 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and removal of the solvent gave the desired indole 25 (48.2 mg, 87%) as an intense, 
black-purple solid, mp 168-170 ˚C (dec.). Rf (10% EtOAc:hexane) 0.56. UV-Vis (acetone) λmax/nm 
(ε, M-1cm-1) 328 (5039), 535 (2864). 1H NMR (500 MHz, CDCl3) δ 10.09 (s, 1H, NH), 7.56 (d, J = 
8.2 Hz, 1H, H4), 7.51 – 7.48 (m, 2H, H4ꞌ, H6ꞌꞌ), 7.48 – 7.41 (m, 3H, H6, H7, H6ꞌ), 7.36 – 7.31 (m, 
1H, H4ꞌꞌ), 7.21 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.18 – 7.08 (m, 3H, H5, H5ꞌ, H5ꞌꞌ), 7.04 (d, J = 7.3 Hz, 1H, 
H3ꞌꞌ), 3.72 (s, 3H, -OCH3). 
13C{1H} NMR (126 MHz, CDCl3) δ 195.1 (C3ꞌ), 162.1 (C7aꞌ), 157.6 (C2ꞌ), 
154.9 (C2ꞌꞌ), 138.1 (C7a), 137.3 (C6ꞌ), 132.1 (C6ꞌꞌ), 129.1 (C4ꞌꞌ), 128.5 (C3), 127.6 (C5ꞌ), 126.1 (C6), 
125.6 (C3a), 125.0 (C4ꞌ), 123.4 (C2), 122.4 (C3aꞌ), 122.1 (C4), 121.9 (C1ꞌꞌ), 121.8 (C7ꞌ), 121.0 (C5ꞌꞌ), 
120.6 (C5), 111.9 (C7), 111.3 (C3ꞌꞌ), 55.6 (-OCH3). IR (neat) 3402 (m), 1718 (s), 1549 (s), 1451 (m), 
1326 (s), 1257 (m), 1239 (s), 1026 (m), 875 (m), 793 (m), 745 (s), 691 (s) cm-1. HRESI-MS calcd. 
for C23H17N2O2
+ 353.1290, found 353.1298. 
3-(2,4-dimethoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (26) 
Prepared via General Procedure F, using 29.1 mg (0.0603 mmol) of 11 in neat TFA (2 mL), and the 
mixture allowed to stir overnight. The resulting dark purple residue was triturated with hexane to give 
the desired indole 26 (18.9 mg, 77%†) as an intense, black-purple solid, mp 119-120 ˚C. Rf (20% 
EtOAc:hexane) 0.25. UV-Vis (acetone) λmax/nm (ε, M
-1cm-1) 326 (4530), 546 (1547). 1H NMR (400 
MHz, CDCl3) δ 10.15 (s, 1H, NH), 7.57 (d, J = 8.1 Hz, 1H, H4), 7.50 (d, J = 7.2 Hz, 1H, H4ꞌ), 7.48 
– 7.40 (m, 3H, H7, H6ꞌ, H6ꞌꞌ), 7.32 (app t, J = 7.6 Hz, 1H, H6), 7.22 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.17 – 
7.08 (m, 2H, H5, H5ꞌ), 6.67 – 6.60 (m, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.91 (s, 3H, C4ꞌꞌ-OCH3), 3.70 (s, 3H, C2ꞌꞌ-
OCH3). 
13C{1H} NMR (101 MHz, CDCl3) δ 195.2 (C3ꞌ), 162.2 (C4ꞌꞌ), 160.8 (C7aꞌ), 158.6 (C2ꞌ), 154.8 
(C2ꞌꞌ), 138.2 (C7a), 137.2 (C6ꞌ), 132.5 (C6ꞌꞌ), 128.6 (C3a), 127.4 (C5ꞌ), 126.1 (C6), 125.5 (C3), 125.0 
(C4ꞌ), 122.4 (C2), 122.1 (C3aꞌ), 122.0 (C4), 121.9 (C7ꞌ), 120.8 (C5), 116.2 (C1ꞌꞌ), 111.9 (C7), 104.4 
(C5ꞌꞌ), 99.3 (C3ꞌꞌ), 55.6 (C4ꞌꞌ-OCH3), 55.5 (C2ꞌꞌ-OCH3). IR (neat) 3414 (w), 2928 (m), 2360 (w), 1718 
(s), 1612 (s), 1549 (s), 1451 (s), 1327 (m), 1301 (m), 1262 (m), 1209 (s), 1159 (s), 1032 (m), 876 (m), 
746 (s), 692 (w) cm-1. HRESI-MS calcd. for C24H18N2O3Na
+ 405.1215, found 405.1213. 
3-(2-chlorophenyl)-1H,3'H-[2,2'-biindol]-3'-one (27) 
Prepared via General Procedure F, using 41.4 mg (0.0906 mmol) of 12, and the mixture allowed to 
stir overnight. The resulting deep burgundy residue was subjected to flash chromatography (20 g 
silica, 10% EtOAc:hexane), and triturated with hexane to give the desired indole 27 (26.4 mg, 81%†) 
as an intense, black-purple solid, mp 203-204 ˚C. Rf (10% EtOAc:hexane) 0.44. UV-Vis (acetone) 
λmax/nm (ε, M
-1cm-1) 328 (3113), 535 (2301). 1H NMR (500 MHz, CDCl3) δ 10.08 (s, 1H, NH), 7.57 
– 7.54 (m, 1H, H6ꞌꞌ), 7.52 – 7.44 (m, 4H, H4, H7, H4ꞌ, H6ꞌ), 7.43 (dd, J = 8.1, 0.8 Hz, 1H, H3ꞌꞌ), 7.41 
– 7.34 (m, 3H, H6, H4ꞌꞌ, H5ꞌꞌ), 7.21 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.20 – 7.13 (m, 1H, H5ꞌ), 7.17 – 7.11 (m, 
1H, H5). 13C{1H} NMR (126 MHz, CDCl3) δ 194.8 (C3ꞌ), 161.8 (C7aꞌ), 154.7 (C2ꞌ), 137.8 (C7a), 
137.3 (C6ꞌ), 134.8 (C2ꞌꞌ), 133.6 (C1ꞌꞌ), 132.6 (C6ꞌꞌ), 129.8 (C3ꞌꞌ), 129.0 (C4ꞌꞌ), 128.4 (C3), 127.9 (C5ꞌ), 
126.6 (C5ꞌꞌ), 126.3 (C6), 125.7 (C3a), 125.1 (C4ꞌ), 124.4 (C2), 122.6 (C3aꞌ), 122.4 (C4), 121.5 (C7ꞌ), 
121.3 (C5), 112.0 (C7). IR (neat) 3407 (w), 2924 (m), 1718 (m), 1554 (s), 1451 (m), 1327 (m), 1163 
(w), 877 (m), 747 (m), 690 (w) cm-1. HRESI-MS calcd. for C22H14
35ClN2O
+ 357.0789, found 
357.0795. 
3-(4-fluorophenyl)-1H,3'H-[2,2'-biindol]-3'-one (28) 
Prepared via General Procedure F, using 33.7 mg (0.0765 mmol) of 13, and a 2 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and triturated with hexane to afford the desired indole 28 (23.2 mg, 89%) as an 
intense, black-purple solid, mp 244-246 ˚C. Rf (10% EtOAc:hexane) 0.20. UV-Vis (acetone) λmax/nm 
(ε, M-1cm-1) 326 (3668), 534 (2307). 1H NMR (400 MHz, CDCl3,
19F-decoupled) δ 10.27 (s, 1H, NH), 
7.68 (d, J = 8.7 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.64 (d, J = 8.2 Hz, 1H, H4), 7.53 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 
– 7.45 (m, 2H, H7, H6ꞌ), 7.36 (app t, J = 7.7 Hz, 1H, H6), 7.23 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.21 – 7.12 
(m, 4H, H5, H5ꞌ, H3ꞌꞌ, H5ꞌꞌ). 13C{1H} NMR (101 MHz, CDCl3) δ 196.2 (C3ꞌ), 162.3 (d, 
1J C-F = 246.6 
Hz, C4ꞌꞌ), 162.0 (C7aꞌ), 153.9 (C2ꞌ), 138.0 (C7a), 137.4 (C6ꞌ), 132.6 (d, 3J C-F = 8.0 Hz, C2ꞌꞌ), 129.6 
(d, 4J C-F = 3.3 Hz, C1ꞌꞌ), 128.0 (C3a), 127.7 (C5ꞌ), 126.3 (C6), 125.4 (C3), 125.1 (C4ꞌ), 124.4 (C2), 
122.3 (C4), 122.0 (C3aꞌ), 121.3 (C7ꞌ), 121.2 (C5), 115.0 (d, 2J C-F = 21.4 Hz, C3ꞌꞌ), 112.0 (C7). 
19F 
NMR (377 MHz, CDCl3, 
1H-decoupled) δ -114.8. IR (neat) 3367 (w), 2998 (m), 1734 (m), 1714 (m), 
1559 (s), 1507 (s), 1340 (m), 1255 (m), 879 (m), 834 (m), 746 (m), 692 (m) cm-1. HRESI-MS calcd. 
for C22H14N2OF
+ 341.1090, found 341.1098. 
3-(pyridin-3-yl)-1H,3'H-[2,2'-biindol]-3'-one (29) 
Prepared via General Procedure F, using 36.8 mg (0.0869 mmol) of 15, and the mixture allowed to 
stir overnight. The resulting deep burgundy residue was subjected to flash chromatography (20 g 
silica, 10% EtOAc:CH2Cl2), and triturated with hexane to give the desired indole 29 (26.4 mg, 92%
†) 
as an intense, black-purple powder, mp 276-277 ˚C (dec.). Rf (10% EtOAc:CH2Cl2) 0.46. UV-Vis 
(acetone) λmax/nm (ε, M
-1cm-1) 326 (5139), 530 (3061). 1H NMR (400 MHz, CDCl3) δ 10.40 (s, 1H, 
NH), 8.95 (broad app. s, 1H, H2ꞌꞌ), 8.65 (broad app. s, 1H, H4ꞌꞌ), 8.04 (d, J = 7.8 Hz, 1H, H6ꞌꞌ), 7.62 
(d, J = 8.2 Hz, 1H, H4), 7.53 – 7.41 (m, 4H, H7, H4ꞌ, H6ꞌ, H5ꞌꞌ), 7.36 (ddd, J = 8.2, 7.0, 0.9 Hz, 1H, 
H6), 7.23 – 7.12 (m, 3H, H5, H5ꞌ, H7ꞌ). 13C{1H} NMR (101 MHz, CDCl3) δ 195.9 (C3ꞌ), 161.8 (C7aꞌ), 
153.9 (C2ꞌ), 151.6 (br, C2ꞌꞌ), 148.2 (br, C4ꞌꞌ), 138.3 (br, C6ꞌꞌ), 138.1 (C7a), 137.6 (C6ꞌ), 127.94 (C5ꞌ), 
127.92 (C3a), 127.7 (C3), 126.5 (C6), 125.3 (C4ꞌ), 125.0 (C1ꞌꞌ), 123.1 (br, C5ꞌꞌ), 122.5 (C5), 122.2 
(C2), 122.0 (C3aꞌ), 121.8 (C4), 120.9 (C7ꞌ), 112.3 (C7). IR (neat) 3393 (w), 1718 (s), 1556 (s), 1507 
(w), 1452 (m), 1340 (w), 1261 (w), 1167 (w), 877 (m), 759 (w), 745 (m), 732 (m), 714 (w), 688 (m) 
cm-1. HRESI-MS calcd. for C21H14N3O
+ 324.1137, found 324.1142. 
3-(thiophen-2-yl)-1H,3'H-[2,2'-biindol]-3'-one (30) 
Prepared via General Procedure F, using 49.0 mg (0.114 mmol) of 14, and a 1.5 h reaction time. The 
resulting dark purple residue was subjected to flash chromatography (20 g silica, 10% 
EtOAc:hexane), and removal of the solvent gave the desired indole 30 (36.0 mg, 96%) as an intense, 
black-purple powder, mp >300 ˚C. Rf (10% EtOAc:hexane) 0.42. UV-Vis (acetone) λmax/nm (ε, M
-
1cm-1) 328 (4194), 545 (1342). 1H NMR (500 MHz, CDCl3) δ 10.36 (s, 1H, NH), 7.97 (dd, J = 8.2, 
0.9 Hz, 1H, H4), 7.76 (dd, J = 3.6, 1.2 Hz, 1H, H5ꞌꞌ), 7.55 (ddd, J = 7.1, 1.4, 0.6 Hz, 1H, H4ꞌ), 7.53 – 
7.46 (m, 3H, H7, H6ꞌ, H3ꞌꞌ), 7.37 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H, H6), 7.33 (d, J = 7.6 Hz, 1H, H7ꞌ), 
7.23 (dd, J = 5.1, 3.6 Hz, 1H, H4ꞌꞌ), 7.22 – 7.17 (m, 2H, H5, H5ꞌ). 13C{1H} NMR (126 MHz, CDCl3) 
δ 196.4 (C3ꞌ), 162.1 (C7aꞌ), 153.5 (C2ꞌ), 139.2 (C2ꞌꞌ), 137.9 (C7a), 137.5 (C6ꞌ), 134.7 (C3), 129.5 
(C5ꞌꞌ), 127.8 (C3a), 127.7 (C4ꞌꞌ), 127.1 (C5ꞌ), 126.4 (C3ꞌꞌ), 126.2 (C6), 125.2 (C4ꞌ), 125.0 (C2), 122.4 
(C7ꞌ), 122.0 (C4), 121.4 (C5), 119.2 (C3aꞌ), 111.9 (C7). IR (neat) 3366 (w), 1734 (s), 1653 (s), 1558 
(s), 1507 (s), 1340 (w), 1250 (w), 876 (w), 758 (w), 745 (m), 691 (m) cm-1. HRESI-MS calcd. for 
C20H13N2OS
+ 329.0749, found 329.0750. 
Biological testing 
The antiplasmodial activity of the experimental compounds was assessed against Plasmodium 
falciparum 3D7 (chloroquine sensitive) and Dd2 (drug resistant) parasite strains. Preliminary 
cytotoxicity assessment was carried out using Human Embryonic Kidney (HEK293) cells. The 
compounds were tested in a 22-point concentration-response range of 80 µM – 0.01 nM. Artesunate, 
dihydroartemisinin (DHA), chloroquine, puromycin and pyrimethamine were used as reference 
compounds / drugs, and were tested in both experiments using 22-point concentration-response range 
of 40 µM – 0.01 nM (10 µM – 0.003 nM for DHA and artesunate). 0.4% DMSO and 5 µM puromycin 
were used as negative and positive in-plate controls, respectively. 
Antimalarial assay. Plasmodium falciparum 3D7 (chloroquine sensitive) and Dd2 (drug resistant) 
parasite strains were maintained in RPMI 1640 supplemented with 25 mM HEPES, 5% AB human 
male serum, 2.5 mg/ml Albumax II, and 0.37 mM hypoxanthine.  
Parasites were subjected to two rounds of sorbitol synchronization before undergoing compound 
treatment. Ring stage parasites at 2% parasitemia and 0.3% hematocrit were exposed to the 
experimental compounds in 384-wells imaging CellCarrier microplates (PerkinElmer), as previously 
described.40 Plates were incubated for 72 h at 37 °C, 90% N2, 5% CO2, 5% O2, parasites then stained 
with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI) in permeabilization buffer (PBS, 
5mM EDTA, 0.5ug/ml DAPI, 0.01% Triton X-100, and 0.001% saponin), and imaged with an Opera 
QEHS micro-plate confocal imaging system (PerkinElmer) using 20x water-immersion objective and 
405 nm excitation, 450/50 nm emission filters. Images were analysed using a custom Acapella spot 
detection script, to quantify DAPI-stained parasites in each well, as previously described.40 
Cytotoxicity Assay. Human Embryonic Kidney cells (HEK293) were maintained in DMEM medium 
supplemented with 10% FBS. Cells were seeded at 2,000 cells/well in TC-treated 384-wells clear-
bottom plates (Greiner), 24h before the addition of compounds. Compounds were added to the plates 
as described above, then the plates were incubated for 72h at 37 °C, 5% CO2. At the end of the 
incubation, the media was removed from the wells and replaced with an equal volume of 44 µM 
resazurin. After an additional 5-6 hours incubation at standard conditions, the total fluorescence 
(excitation/emission: 530 nm / 595 nm) was measured using an Envision plate reader (PerkinElmer).  
Raw data from each assay was normalized using the in-plate positive and negative controls to obtain 
normalized % inhibition data, which was then used to calculate IC50 values, through a 4 parameter 
logistic curve fitting in Prism v 6.0 (GraphPad). 
The experiments were carried out in two biological replicates, each consisting of two technical 
repeats. 
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